Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript)

Johnson & Johnson (NYSE:JNJ) Leerink Partners Global Biopharma Conference March 12, 2024 1:00 PM ET Company Participants Joe Wolk - Chief Financial Officer Raychel Kruper - Senior Director of Investor Relations Conference Call Participants David Risinger - Leerink Partners David Risinger Okay. So, we're going to get started here. Sorry, we're starting two minutes late. My apologies. So, my name is Dave Risinger. If you don't know me, I cover diversified biopharmaceuticals for Leerink Partners. And it's very ...